Abstract
BackgroundHigh myopia (HM) refers to an eye refractive error exceeding −5.00 D, significantly elevating blindness risk. The underlying mechanism of HM remains elusive. Given the extensive genetic heterogeneity and vast genetic base opacity, it is imperative to identify more causative genes and explore their pathogenic roles in HM.MethodsWe employed exome sequencing to pinpoint the causal gene in an HM family. Sanger sequencing was used to confirm and analyse the gene mutations in this family and 200 sporadic HM cases. Single-cell RNA sequencing was conducted to evaluate the gene’s expression patterns in developing human and mouse retinas. The CRISPR/Cas9 system facilitated the gene knockout cells, aiding in the exploration of the gene’s function and its mutations. Immunofluorescent staining and immunoblot techniques were applied to monitor the functional shifts of the gene mutations at the cellular level.ResultsA suspected nonsense mutation (c.C172T, p.Q58X) inCCDC66was found to be co-segregated with the HM phenotype in the family. Additionally, six other rare variants were identified among the 200 sporadic patients.CCDC66was consistently expressed in the embryonic retinas of both humans and mice. Notably, in CCDC66-deficient HEK293 cells, there was a decline in cell proliferation, microtube polymerisation rate and ace-tubulin level. Furthermore, the mutated CCDC66 failed to synchronise with the tubulin system during Hela cell mitosis, unlike its wild type counterpart.ConclusionsOur research indicates that theCCDC66variant c.C172T is associated with HM. A deficiency in CCDC66 might disrupt cell proliferation by influencing the mitotic process during retinal growth, leading to HM.
Funder
National Key Research and Development Program of China
The Natural Science Foundation of Hunan Province
The key R&D program of Hunan Province
National Natural Science Foundation of China
Subject
Genetics (clinical),Genetics
Reference38 articles.
1. Organization WH . The impact of myopia and high myopia: Report of the Joint World Health Organization–Brien Holden Vision Institute global scientific meeting on myopia. Geneva, Switzerland: World Health Organization, 2015.
2. World Health O . International statistical classification of diseases and related health problems: world health organization. 2010.
3. Sankaridurg P , Tahhan N , Kandel H , et al . IMI impact of myopia. Invest Ophthalmol Vis Sci 2021;62:2. doi:10.1167/iovs.62.5.2
4. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
5. Bio-environmental factors associated with myopia: an updated review;Galvis;Archivos de La Sociedad Española de Oftalmología (English Edition),2017